Medica
Meet our team at Medica 2023 from Nov 13 - 16.
Your company is already operating in Germany and you would now like to export worldwide?
Meet our team at Medica 2023 from Nov 13 - 16.
Meet our team at BIO Europe from Nov 06-08 in Munich.
Japanese pharmaceuticals giant Takeda has put hundreds of millions of euros in recent years into its location in the southwestern German town of Singen to produce its anti-dengue-fever vaccine “Qdenga.”
The mood in German pharmaceuticals is bright, with companies looking to increase investment.
As part of the Internationalization of Regions in Structural Transformation (ISW) program, Germany Trade & Invest is hosting an investor event for American Companies and Institutions about market opportunities in the healthcare industry.
Germany's life sciences sector is proving attractive to start-up investors and international health companies alike.
The EU’s regulatory authority has cleared the way for anti-Covid-19 inoculations to begin in Germany and other members of the European bloc.
German pharmaceutical company BioNTech and Pfizer have presented the first results of their phase 3 study to develop a Covid-19 vaccine that should provide more than 90 percent protection.
Germany's medical technology sector secured more than EUR 2 billion in investment in 2021, with start-up companies and larger corporations alike developing great innovations.
Germany's life sciences sector was the top medical device FDI destination in 2019 and 2020. Companies including Bayer and BioNTech are also expanding their footprint in the country.